نتایج جستجو برای: curcuminoids

تعداد نتایج: 460  

Journal: :Journal of natural products 2011
John Cuomo Giovanni Appendino Adam S Dern Erik Schneider Toni P McKinnon Mark J Brown Stefano Togni Brian M Dixon

The relative absorption of a standardized curcuminoid mixture and its corresponding lecithin formulation (Meriva) was investigated in a randomized, double-blind, crossover human study. Clinically validated dosages were used for both products, and plasma levels of all three major curcuminoids [curcumin (1a), demethoxycurcumin (1b), and bisdemethoxycurcumin (1c)] were evaluated. Total curcuminoid...

2013
Ying-Bo Li Zhang-Feng Zhong Mei-Wan Chen Jiao-Lin Bao Guo-Sheng Wu Qing-Wen Zhang Simon Ming-Yuen Lee Pui-Man Hoi Yi-Tao Wang

Curcuminoids are well known for their capabilities to combat risk factors that are associated with ageing and cellular senescence. Recent reports have demonstrated that curcuminoids can extend the lifespan of model organisms. However, the underlying mechanisms by which these polyphenic compounds exert these beneficial effects remain unknown. In this study, t-BHP-induced premature senescence mod...

2009
Durg Vijay Singh Krishna Misra

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Re...

2012
Ibrahim Jantan Fadlina Chany Saputri Muhammad Naeem Qaisar Fhataheya Buang

The antioxidant activity of the curcuminoids of Curcuma domestica L. and C. xanthorrhiza Roxb. and eight compounds which are prevalent constituents of their rhizome oils were investigated in an effort to correlate human low-density lipoprotein (LDL) antioxidant activity with the effect of the herbs and their components. The antioxidant activity was examined using thiobarbituric acid reactive su...

2005

n Sept. 30, 2004, the pharmaceutical giant Merck & Co. Inc. announced a voluntary worldwide withdrawal of VIOXX (rofecoxib), its arthritis and acute pain COX-2 inhibiting medication. The company’s decision was based on data from a new, three-year prospective, randomized, placebo-controlled clinical trial, which showed that after 18 months of use, VIOXX increased relative risk for confirmed card...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید